Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC M&A Activity 2021

May 11, 2021

5250_rns_2021-05-11_cd2c27c1-d47b-4c95-8ebc-8632daac4990.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

Form 8.3 - Willis Towers Watson plc - Amendment

Ap19

FORM 8.3 - Amendment to sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 07 May 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,685,698 1.31% 168,754 0.13%
(2) Derivatives (other than options):
72,359 0.06% 0 0.00%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,764,157 1.37% 174,854 0.14%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 1 271.0500 USD
Purchase 1 269.2600 USD
Purchase 100 267.5500 USD
Purchase 100 268.5900 USD
Purchase 100 269.1600 USD
Purchase 100 269.1400 USD
Purchase 280 269.5972 USD
Purchase 291 270.4761 USD
Purchase 334 270.0700 USD
Purchase 400 269.5112 USD
Purchase 800 269.3493 USD
Purchase 800 268.9125 USD
Purchase 900 269.5233 USD
Purchase 910 268.5916 USD
Purchase 1,100 269.2400 USD
Purchase 1,105 270.0643 USD
Purchase 1,197 269.5992 USD
Purchase 1,200 268.9508 USD
Purchase 1,600 270.3597 USD
Purchase 1,867 269.3192 USD
Purchase 2,062 268.7040 USD
Purchase 2,688 268.8357 USD
Purchase 5,217 269.7788 USD
Purchase 5,630 268.6331 USD
Purchase 6,353 269.7414 USD
Purchase 6,957 269.5363 USD
Purchase 8,173 269.5084 USD
Purchase 9,371 269.6119 USD
Purchase 11,740 268.6606 USD
Purchase 21,763 270.0595 USD
Purchase 25,902 269.0358 USD
Purchase 35,000 269.0296 USD
Sale 1 263.8300 USD
Sale 7 270.6900 USD
Sale 8 270.6500 USD
Sale 10 270.6560 USD
Sale 12 269.3525 USD
Sale 15 270.3226 USD
Sale 19 270.2800 USD
Sale 20 271.2700 USD
Sale 21 270.3466 USD
Sale 21 270.4200 USD
Sale 21 270.5023 USD
Sale 21 270.4900 USD
Sale 28 270.5200 USD
Sale 28 270.5375 USD
Sale 28 268.6300 USD
Sale 28 270.4387 USD
Sale 35 270.5390 USD
Sale 40 270.5396 USD
Sale 40 268.7100 USD
Sale 58 268.6100 USD
Sale 90 270.3500 USD
Sale 91 270.4500 USD
Sale 100 268.5600 USD
Sale 100 268.8600 USD
Sale 100 270.2600 USD
Sale 100 271.0000 USD
Sale 114 268.7637 USD
Sale 142 268.7184 USD
Sale 150 268.7433 USD
Sale 200 270.3700 USD
Sale 200 268.6700 USD
Sale 200 271.3250 USD
Sale 220 269.8775 USD
Sale 300 270.3666 USD
Sale 300 269.5900 USD
Sale 353 268.7981 USD
Sale 489 268.7085 USD
Sale 800 270.3597 USD
Sale 900 270.3396 USD
Sale 978 269.2055 USD
Sale 1,235 269.4977 USD
Sale 1,366 270.5178 USD
Sale 1,457 270.0700 USD
Sale 1,556 270.3928 USD
Sale 1,756 269.2561 USD
Sale 2,229 270.5325 USD
Sale 2,519 269.9483 USD
Sale 2,676 269.6415 USD
Sale 3,176 269.7549 USD
Sale 3,440 268.7969 USD
Sale 5,116 269.8129 USD
Sale 5,297 269.4086 USD
Sale 6,267 270.1443 USD
Sale 8,342 269.4915 USD
Sale 8,631 268.6418 USD
Sale 8,818 269.4832 USD
Sale 13,812 269.3654 USD
Sale 70,000 269.0296 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 11 May 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210511005998/en/

BARCLAYS PLC